China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Income Statement
Earnings Waterfall
China Resources Boya Bio pharmaceutical Group Co Ltd
Revenue
|
2.7B
CNY
|
Cost of Revenue
|
-1.3B
CNY
|
Gross Profit
|
1.4B
CNY
|
Operating Expenses
|
-846.1m
CNY
|
Operating Income
|
549.8m
CNY
|
Other Expenses
|
-312.3m
CNY
|
Net Income
|
237.5m
CNY
|
Income Statement
China Resources Boya Bio pharmaceutical Group Co Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
245
N/A
|
278
+13%
|
322
+16%
|
366
+14%
|
438
+20%
|
452
+3%
|
472
+5%
|
498
+5%
|
543
+9%
|
615
+13%
|
720
+17%
|
839
+17%
|
947
+13%
|
994
+5%
|
1 086
+9%
|
1 133
+4%
|
1 461
+29%
|
1 732
+19%
|
2 012
+16%
|
2 307
+15%
|
2 451
+6%
|
2 609
+6%
|
2 735
+5%
|
2 867
+5%
|
2 909
+1%
|
2 908
0%
|
2 861
-2%
|
2 795
-2%
|
2 684
-4%
|
2 705
+1%
|
2 651
-2%
|
2 706
+2%
|
2 651
-2%
|
2 633
-1%
|
2 754
+5%
|
2 722
-1%
|
2 759
+1%
|
2 910
+5%
|
2 901
0%
|
2 866
-1%
|
2 652
-7%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(109)
|
(122)
|
(138)
|
(149)
|
(168)
|
(171)
|
(178)
|
(186)
|
(195)
|
(236)
|
(273)
|
(327)
|
(350)
|
(374)
|
(383)
|
(379)
|
(491)
|
(630)
|
(773)
|
(897)
|
(927)
|
(1 005)
|
(1 051)
|
(1 125)
|
(1 126)
|
(1 169)
|
(1 226)
|
(1 215)
|
(1 225)
|
(1 279)
|
(1 192)
|
(1 214)
|
(1 141)
|
(1 139)
|
(1 230)
|
(1 231)
|
(1 250)
|
(1 400)
|
(1 411)
|
(1 430)
|
(1 256)
|
|
Gross Profit |
137
N/A
|
156
+14%
|
184
+18%
|
218
+18%
|
270
+24%
|
280
+4%
|
294
+5%
|
311
+6%
|
348
+12%
|
379
+9%
|
446
+18%
|
512
+15%
|
597
+17%
|
620
+4%
|
703
+13%
|
753
+7%
|
969
+29%
|
1 102
+14%
|
1 240
+13%
|
1 410
+14%
|
1 524
+8%
|
1 604
+5%
|
1 684
+5%
|
1 742
+3%
|
1 783
+2%
|
1 740
-2%
|
1 635
-6%
|
1 580
-3%
|
1 459
-8%
|
1 426
-2%
|
1 458
+2%
|
1 493
+2%
|
1 509
+1%
|
1 494
-1%
|
1 525
+2%
|
1 491
-2%
|
1 508
+1%
|
1 510
+0%
|
1 490
-1%
|
1 436
-4%
|
1 396
-3%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(60)
|
(75)
|
(92)
|
(110)
|
(147)
|
(151)
|
(161)
|
(166)
|
(186)
|
(201)
|
(222)
|
(247)
|
(282)
|
(289)
|
(345)
|
(399)
|
(564)
|
(669)
|
(768)
|
(898)
|
(967)
|
(1 021)
|
(1 095)
|
(1 139)
|
(1 253)
|
(1 197)
|
(1 150)
|
(1 147)
|
(1 127)
|
(1 101)
|
(1 106)
|
(1 077)
|
(1 050)
|
(1 102)
|
(1 090)
|
(1 077)
|
(993)
|
(1 012)
|
(1 004)
|
(954)
|
(846)
|
|
Selling, General & Administrative |
(60)
|
(75)
|
(91)
|
(108)
|
(120)
|
(149)
|
(159)
|
(164)
|
(148)
|
(201)
|
(223)
|
(246)
|
(221)
|
(279)
|
(335)
|
(381)
|
(511)
|
(655)
|
(750)
|
(874)
|
(902)
|
(958)
|
(1 040)
|
(1 087)
|
(1 135)
|
(1 126)
|
(1 059)
|
(1 060)
|
(1 007)
|
(1 032)
|
(1 018)
|
(991)
|
(943)
|
(970)
|
(980)
|
(963)
|
(896)
|
(915)
|
(907)
|
(860)
|
(746)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(42)
|
0
|
0
|
(9)
|
(35)
|
0
|
0
|
(9)
|
(42)
|
(39)
|
(57)
|
(64)
|
(89)
|
(99)
|
(99)
|
(95)
|
(84)
|
(79)
|
(97)
|
(93)
|
(54)
|
(58)
|
(38)
|
(43)
|
(45)
|
(53)
|
(65)
|
(62)
|
(63)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(37)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(47)
|
0
|
0
|
0
|
(43)
|
|
Other Operating Expenses |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(2)
|
(2)
|
(2)
|
(3)
|
0
|
1
|
(1)
|
(5)
|
(11)
|
(10)
|
(9)
|
(4)
|
(14)
|
(18)
|
(15)
|
(3)
|
(24)
|
2
|
12
|
(1)
|
28
|
7
|
8
|
(0)
|
10
|
10
|
8
|
(5)
|
(74)
|
(72)
|
(71)
|
(5)
|
(45)
|
(32)
|
(32)
|
6
|
|
Operating Income |
77
N/A
|
82
+6%
|
92
+13%
|
108
+17%
|
123
+14%
|
129
+5%
|
133
+3%
|
145
+9%
|
162
+12%
|
178
+10%
|
224
+26%
|
265
+18%
|
315
+19%
|
330
+5%
|
358
+8%
|
354
-1%
|
406
+15%
|
433
+7%
|
472
+9%
|
513
+9%
|
558
+9%
|
583
+4%
|
589
+1%
|
602
+2%
|
529
-12%
|
543
+3%
|
484
-11%
|
433
-11%
|
332
-23%
|
325
-2%
|
353
+9%
|
416
+18%
|
460
+11%
|
393
-15%
|
435
+11%
|
414
-5%
|
516
+25%
|
497
-4%
|
486
-2%
|
482
-1%
|
550
+14%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
17
|
17
|
13
|
9
|
6
|
32
|
33
|
34
|
5
|
5
|
5
|
7
|
11
|
29
|
30
|
29
|
4
|
(1)
|
(6)
|
(12)
|
7
|
6
|
3
|
5
|
(17)
|
(18)
|
(22)
|
(19)
|
2
|
15
|
23
|
22
|
64
|
53
|
103
|
142
|
69
|
115
|
103
|
121
|
135
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
19
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
0
|
0
|
(2)
|
(2)
|
(1)
|
(1)
|
(81)
|
(1)
|
(0)
|
(0)
|
(54)
|
0
|
0
|
0
|
(330)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
4
|
4
|
5
|
7
|
7
|
9
|
4
|
2
|
6
|
4
|
6
|
5
|
3
|
6
|
8
|
4
|
1
|
5
|
6
|
9
|
8
|
5
|
6
|
8
|
6
|
5
|
(0)
|
(6)
|
(3)
|
(8)
|
(7)
|
(1)
|
1
|
(1)
|
(1)
|
(3)
|
0
|
(1)
|
(3)
|
(1)
|
(1)
|
|
Pre-Tax Income |
98
N/A
|
102
+5%
|
110
+7%
|
124
+13%
|
136
+10%
|
170
+25%
|
170
+0%
|
181
+6%
|
198
+9%
|
186
-6%
|
234
+26%
|
277
+18%
|
328
+19%
|
366
+11%
|
396
+8%
|
387
-2%
|
431
+11%
|
436
+1%
|
472
+8%
|
510
+8%
|
572
+12%
|
593
+4%
|
598
+1%
|
615
+3%
|
520
-15%
|
531
+2%
|
462
-13%
|
409
-12%
|
328
-20%
|
330
+1%
|
368
+11%
|
436
+18%
|
443
+2%
|
444
+0%
|
537
+21%
|
552
+3%
|
532
-4%
|
612
+15%
|
587
-4%
|
603
+3%
|
354
-41%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(15)
|
(16)
|
(17)
|
(19)
|
(21)
|
(26)
|
(27)
|
(28)
|
(31)
|
(29)
|
(36)
|
(43)
|
(51)
|
(59)
|
(66)
|
(64)
|
(66)
|
(65)
|
(69)
|
(75)
|
(87)
|
(91)
|
(90)
|
(97)
|
(78)
|
(82)
|
(73)
|
(62)
|
(53)
|
(51)
|
(57)
|
(63)
|
(85)
|
(83)
|
(96)
|
(98)
|
(87)
|
(99)
|
(95)
|
(112)
|
(106)
|
|
Income from Continuing Operations |
82
|
86
|
93
|
105
|
115
|
144
|
143
|
152
|
167
|
157
|
198
|
234
|
278
|
307
|
331
|
323
|
365
|
372
|
403
|
434
|
485
|
502
|
507
|
518
|
442
|
450
|
390
|
347
|
275
|
279
|
311
|
373
|
358
|
361
|
441
|
454
|
445
|
513
|
492
|
491
|
248
|
|
Income to Minority Interest |
0
|
(2)
|
(4)
|
(9)
|
(11)
|
(13)
|
(13)
|
(15)
|
(15)
|
(12)
|
(12)
|
(7)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(10)
|
(13)
|
(15)
|
(16)
|
(16)
|
(16)
|
(17)
|
(16)
|
(17)
|
(15)
|
(15)
|
(15)
|
(14)
|
(14)
|
(13)
|
(14)
|
(14)
|
(15)
|
(15)
|
(13)
|
(14)
|
(12)
|
(13)
|
(11)
|
|
Net Income (Common) |
82
N/A
|
85
+3%
|
89
+5%
|
96
+9%
|
104
+8%
|
130
+25%
|
130
+0%
|
138
+6%
|
152
+10%
|
145
-4%
|
187
+29%
|
227
+22%
|
272
+20%
|
301
+11%
|
324
+8%
|
316
-3%
|
357
+13%
|
362
+1%
|
390
+8%
|
419
+8%
|
469
+12%
|
486
+4%
|
491
+1%
|
501
+2%
|
426
-15%
|
433
+2%
|
374
-14%
|
332
-11%
|
260
-22%
|
265
+2%
|
297
+12%
|
360
+21%
|
345
-4%
|
347
+1%
|
426
+23%
|
439
+3%
|
432
-2%
|
499
+15%
|
479
-4%
|
478
0%
|
237
-50%
|
|
EPS (Diluted) |
0.24
N/A
|
0.25
+4%
|
0.26
+4%
|
0.28
+8%
|
0.31
+11%
|
0.38
+23%
|
0.38
N/A
|
0.4
+5%
|
0.44
+10%
|
0.36
-18%
|
0.46
+28%
|
0.56
+22%
|
0.68
+21%
|
0.75
+10%
|
0.81
+8%
|
0.79
-2%
|
0.89
+13%
|
0.9
+1%
|
0.9
N/A
|
0.96
+7%
|
1.11
+16%
|
1.14
+3%
|
1.15
+1%
|
1.14
-1%
|
1
-12%
|
1.02
+2%
|
0.88
-14%
|
0.79
-10%
|
0.6
-24%
|
0.61
+2%
|
0.68
+11%
|
0.82
+21%
|
0.79
-4%
|
0.7
-11%
|
0.81
+16%
|
0.87
+7%
|
0.86
-1%
|
0.98
+14%
|
0.95
-3%
|
0.95
N/A
|
0.47
-51%
|